SGX: IX Biopharma (42C)       IX BIOPHARMA LTD.
Last Price Today's Change   Day's Range   Trading Volume
0.215   -0.005 (2.27%)  0.215 - 0.22  63


Avg Volume (4 weeks):0
52 Weeks Range:0.18 - 0.22
52 Weeks Price Volatility (%):
Average Price Target:-


Date Subject
19-Feb-2019 Phillip Capital Morning Note

Business Background

iX Biopharma Ltd., a specialty pharmaceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Australia. The company operates in two segments, Specialty Pharmaceutical and Chemical Analysis. It leverages its patented sublingual drug delivery technology, WaferiX, to develop proprietary products that incorporate pharmacologically active compounds that have been approved by regulatory bodies. Its products include Wafermine, a sublingual ketamine oral wafer for the management of moderate to severe pain; BnoX, a sublingual buprenorphine oral wafer for the treatment of moderate to severe pain; PheoniX, a product that contains sildenafil citrate for the treatment of male erectile dysfunction; WafeRest, a sublingual melatonin wafer supplement for alleviating jet lag and improving sleep quality; and Wafernyl, a sublingual wafer with fentanyl for breakthrough cancer pain. The company also provides laboratory services; and promotes and markets nutritional and supplements products. iX Biopharma Ltd. was founded in 2008 and is headquartered in Singapore.

  Be the first to like this.


96  224  155  628 

Top 10 Active Counters
 AsiaMedic 0.018+0.005 
 Medtecs Intl 0.092+0.04 
 DISA 0.0030.00 
 Healthway Med 0.04+0.012 
 ThaiBev 0.815-0.035 
 Ntegrator Intl 0.013-0.002 
 NauticAWT 0.010.00 
 Thomson Medical 0.063+0.001 
 Jiutian Chemical 0.02-0.002 
 AusGroup^ 0.045-0.003 
Partners & Brokers